Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Endometriosis Drugs Market Size Growth Rate by Type: 2024 VS 2022 VS 2034
1.2.2 Hormonal Therapy
1.2.3 Add-back Medication
1.2.4 Progestogens
1.2.5 Chinese Herbs
1.3 Market by Application
1.3.1 Global Endometriosis Drugs Market Growth by Application: 2024 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Endometriosis Drugs Market Perspective (2024-2034)
2.2 Endometriosis Drugs Growth Trends by Region
2.2.1 Global Endometriosis Drugs Market Size by Region: 2024 VS 2022 VS 2034
2.2.2 Endometriosis Drugs Historic Market Size by Region (2024-2024)
2.2.3 Endometriosis Drugs Forecasted Market Size by Region (2024-2034)
2.3 Endometriosis Drugs Market Dynamics
2.3.1 Endometriosis Drugs Industry Trends
2.3.2 Endometriosis Drugs Market Drivers
2.3.3 Endometriosis Drugs Market Challenges
2.3.4 Endometriosis Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Endometriosis Drugs Players by Revenue
3.1.1 Global Top Endometriosis Drugs Players by Revenue (2024-2024)
3.1.2 Global Endometriosis Drugs Revenue Market Share by Players (2024-2024)
3.2 Global Endometriosis Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Endometriosis Drugs Revenue
3.4 Global Endometriosis Drugs Market Concentration Ratio
3.4.1 Global Endometriosis Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Endometriosis Drugs Revenue in 2022
3.5 Endometriosis Drugs Key Players Head office and Area Served
3.6 Key Players Endometriosis Drugs Product Solution and Service
3.7 Date of Enter into Endometriosis Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Endometriosis Drugs Breakdown Data by Type
4.1 Global Endometriosis Drugs Historic Market Size by Type (2024-2024)
4.2 Global Endometriosis Drugs Forecasted Market Size by Type (2024-2034)
5 Endometriosis Drugs Breakdown Data by Application
5.1 Global Endometriosis Drugs Historic Market Size by Application (2024-2024)
5.2 Global Endometriosis Drugs Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Endometriosis Drugs Market Size (2024-2034)
6.2 North America Endometriosis Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
6.3 North America Endometriosis Drugs Market Size by Country (2024-2024)
6.4 North America Endometriosis Drugs Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Endometriosis Drugs Market Size (2024-2034)
7.2 Europe Endometriosis Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
7.3 Europe Endometriosis Drugs Market Size by Country (2024-2024)
7.4 Europe Endometriosis Drugs Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Endometriosis Drugs Market Size (2024-2034)
8.2 Asia-Pacific Endometriosis Drugs Market Growth Rate by Region: 2024 VS 2022 VS 2034
8.3 Asia-Pacific Endometriosis Drugs Market Size by Region (2024-2024)
8.4 Asia-Pacific Endometriosis Drugs Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Endometriosis Drugs Market Size (2024-2034)
9.2 Latin America Endometriosis Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
9.3 Latin America Endometriosis Drugs Market Size by Country (2024-2024)
9.4 Latin America Endometriosis Drugs Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Endometriosis Drugs Market Size (2024-2034)
10.2 Middle East & Africa Endometriosis Drugs Market Growth Rate by Country: 2024 VS 2022 VS 2034
10.3 Middle East & Africa Endometriosis Drugs Market Size by Country (2024-2024)
10.4 Middle East & Africa Endometriosis Drugs Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Detail
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Endometriosis Drugs Introduction
11.1.4 AbbVie Revenue in Endometriosis Drugs Business (2024-2024)
11.1.5 AbbVie Recent Development
11.2 Astellas Pharma
11.2.1 Astellas Pharma Company Detail
11.2.2 Astellas Pharma Business Overview
11.2.3 Astellas Pharma Endometriosis Drugs Introduction
11.2.4 Astellas Pharma Revenue in Endometriosis Drugs Business (2024-2024)
11.2.5 Astellas Pharma Recent Development
11.3 AstraZeneca
11.3.1 AstraZeneca Company Detail
11.3.2 AstraZeneca Business Overview
11.3.3 AstraZeneca Endometriosis Drugs Introduction
11.3.4 AstraZeneca Revenue in Endometriosis Drugs Business (2024-2024)
11.3.5 AstraZeneca Recent Development
11.4 Debiopharm Group
11.4.1 Debiopharm Group Company Detail
11.4.2 Debiopharm Group Business Overview
11.4.3 Debiopharm Group Endometriosis Drugs Introduction
11.4.4 Debiopharm Group Revenue in Endometriosis Drugs Business (2024-2024)
11.4.5 Debiopharm Group Recent Development
11.5 Evotec
11.5.1 Evotec Company Detail
11.5.2 Evotec Business Overview
11.5.3 Evotec Endometriosis Drugs Introduction
11.5.4 Evotec Revenue in Endometriosis Drugs Business (2024-2024)
11.5.5 Evotec Recent Development
11.6 Kissei Pharmaceutical
11.6.1 Kissei Pharmaceutical Company Detail
11.6.2 Kissei Pharmaceutical Business Overview
11.6.3 Kissei Pharmaceutical Endometriosis Drugs Introduction
11.6.4 Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2024-2024)
11.6.5 Kissei Pharmaceutical Recent Development
11.7 Neurocrine Biosciences
11.7.1 Neurocrine Biosciences Company Detail
11.7.2 Neurocrine Biosciences Business Overview
11.7.3 Neurocrine Biosciences Endometriosis Drugs Introduction
11.7.4 Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2024-2024)
11.7.5 Neurocrine Biosciences Recent Development
11.8 ObsEva
11.8.1 ObsEva Company Detail
11.8.2 ObsEva Business Overview
11.8.3 ObsEva Endometriosis Drugs Introduction
11.8.4 ObsEva Revenue in Endometriosis Drugs Business (2024-2024)
11.8.5 ObsEva Recent Development
11.9 Pfizer
11.9.1 Pfizer Company Detail
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Endometriosis Drugs Introduction
11.9.4 Pfizer Revenue in Endometriosis Drugs Business (2024-2024)
11.9.5 Pfizer Recent Development
11.10 Repros Therapeutics
11.10.1 Repros Therapeutics Company Detail
11.10.2 Repros Therapeutics Business Overview
11.10.3 Repros Therapeutics Endometriosis Drugs Introduction
11.10.4 Repros Therapeutics Revenue in Endometriosis Drugs Business (2024-2024)
11.10.5 Repros Therapeutics Recent Development
11.11 Roivant Sciences
11.11.1 Roivant Sciences Company Detail
11.11.2 Roivant Sciences Business Overview
11.11.3 Roivant Sciences Endometriosis Drugs Introduction
11.11.4 Roivant Sciences Revenue in Endometriosis Drugs Business (2024-2024)
11.11.5 Roivant Sciences Recent Development
11.12 Takeda Pharmaceutical Company
11.12.1 Takeda Pharmaceutical Company Company Detail
11.12.2 Takeda Pharmaceutical Company Business Overview
11.12.3 Takeda Pharmaceutical Company Endometriosis Drugs Introduction
11.12.4 Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2024-2024)
11.12.5 Takeda Pharmaceutical Company Recent Development
11.13 ValiRx
11.13.1 ValiRx Company Detail
11.13.2 ValiRx Business Overview
11.13.3 ValiRx Endometriosis Drugs Introduction
11.13.4 ValiRx Revenue in Endometriosis Drugs Business (2024-2024)
11.13.5 ValiRx Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Endometriosis Drugs Market Size Growth Rate by Type (US$ Million): 2024 VS 2022 VS 2034
Table 2. Key Players of Hormonal Therapy
Table 3. Key Players of Add-back Medication
Table 4. Key Players of Progestogens
Table 5. Key Players of Chinese Herbs
Table 6. Global Endometriosis Drugs Market Size Growth by Application (US$ Million): 2024 VS 2022 VS 2034
Table 7. Global Endometriosis Drugs Market Size by Region (US$ Million): 2024 VS 2022 VS 2034
Table 8. Global Endometriosis Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 9. Global Endometriosis Drugs Market Share by Region (2024-2024)
Table 10. Global Endometriosis Drugs Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Endometriosis Drugs Market Share by Region (2024-2034)
Table 12. Endometriosis Drugs Market Trends
Table 13. Endometriosis Drugs Market Drivers
Table 14. Endometriosis Drugs Market Challenges
Table 15. Endometriosis Drugs Market Restraints
Table 16. Global Endometriosis Drugs Revenue by Players (2024-2024) & (US$ Million)
Table 17. Global Endometriosis Drugs Market Share by Players (2024-2024)
Table 18. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Drugs as of 2022)
Table 19. Ranking of Global Top Endometriosis Drugs Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Endometriosis Drugs Revenue (CR5 and HHI) & (2024-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Endometriosis Drugs Product Solution and Service
Table 23. Date of Enter into Endometriosis Drugs Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Endometriosis Drugs Market Size by Type (2024-2024) & (US$ Million)
Table 26. Global Endometriosis Drugs Revenue Market Share by Type (2024-2024)
Table 27. Global Endometriosis Drugs Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Endometriosis Drugs Revenue Market Share by Type (2024-2034)
Table 29. Global Endometriosis Drugs Market Size by Application (2024-2024) & (US$ Million)
Table 30. Global Endometriosis Drugs Revenue Market Share by Application (2024-2024)
Table 31. Global Endometriosis Drugs Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Endometriosis Drugs Revenue Market Share by Application (2024-2034)
Table 33. North America Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 34. North America Endometriosis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 35. North America Endometriosis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 36. Europe Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 37. Europe Endometriosis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 38. Europe Endometriosis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 39. Asia-Pacific Endometriosis Drugs Market Size Growth Rate by Region (US$ Million): 2024 VS 2022 VS 2034
Table 40. Asia-Pacific Endometriosis Drugs Market Size by Region (2024-2024) & (US$ Million)
Table 41. Asia-Pacific Endometriosis Drugs Market Size by Region (2024-2034) & (US$ Million)
Table 42. Latin America Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 43. Latin America Endometriosis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 44. Latin America Endometriosis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Endometriosis Drugs Market Size Growth Rate by Country (US$ Million): 2024 VS 2022 VS 2034
Table 46. Middle East & Africa Endometriosis Drugs Market Size by Country (2024-2024) & (US$ Million)
Table 47. Middle East & Africa Endometriosis Drugs Market Size by Country (2024-2034) & (US$ Million)
Table 48. AbbVie Company Detail
Table 49. AbbVie Business Overview
Table 50. AbbVie Endometriosis Drugs Product
Table 51. AbbVie Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 52. AbbVie Recent Development
Table 53. Astellas Pharma Company Detail
Table 54. Astellas Pharma Business Overview
Table 55. Astellas Pharma Endometriosis Drugs Product
Table 56. Astellas Pharma Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 57. Astellas Pharma Recent Development
Table 58. AstraZeneca Company Detail
Table 59. AstraZeneca Business Overview
Table 60. AstraZeneca Endometriosis Drugs Product
Table 61. AstraZeneca Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 62. AstraZeneca Recent Development
Table 63. Debiopharm Group Company Detail
Table 64. Debiopharm Group Business Overview
Table 65. Debiopharm Group Endometriosis Drugs Product
Table 66. Debiopharm Group Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 67. Debiopharm Group Recent Development
Table 68. Evotec Company Detail
Table 69. Evotec Business Overview
Table 70. Evotec Endometriosis Drugs Product
Table 71. Evotec Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 72. Evotec Recent Development
Table 73. Kissei Pharmaceutical Company Detail
Table 74. Kissei Pharmaceutical Business Overview
Table 75. Kissei Pharmaceutical Endometriosis Drugs Product
Table 76. Kissei Pharmaceutical Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 77. Kissei Pharmaceutical Recent Development
Table 78. Neurocrine Biosciences Company Detail
Table 79. Neurocrine Biosciences Business Overview
Table 80. Neurocrine Biosciences Endometriosis Drugs Product
Table 81. Neurocrine Biosciences Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 82. Neurocrine Biosciences Recent Development
Table 83. ObsEva Company Detail
Table 84. ObsEva Business Overview
Table 85. ObsEva Endometriosis Drugs Product
Table 86. ObsEva Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 87. ObsEva Recent Development
Table 88. Pfizer Company Detail
Table 89. Pfizer Business Overview
Table 90. Pfizer Endometriosis Drugs Product
Table 91. Pfizer Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 92. Pfizer Recent Development
Table 93. Repros Therapeutics Company Detail
Table 94. Repros Therapeutics Business Overview
Table 95. Repros Therapeutics Endometriosis Drugs Product
Table 96. Repros Therapeutics Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 97. Repros Therapeutics Recent Development
Table 98. Roivant Sciences Company Detail
Table 99. Roivant Sciences Business Overview
Table 100. Roivant Sciences Endometriosis Drugs Product
Table 101. Roivant Sciences Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 102. Roivant Sciences Recent Development
Table 103. Takeda Pharmaceutical Company Company Detail
Table 104. Takeda Pharmaceutical Company Business Overview
Table 105. Takeda Pharmaceutical Company Endometriosis Drugs Product
Table 106. Takeda Pharmaceutical Company Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 107. Takeda Pharmaceutical Company Recent Development
Table 108. ValiRx Company Detail
Table 109. ValiRx Business Overview
Table 110. ValiRx Endometriosis Drugs Product
Table 111. ValiRx Revenue in Endometriosis Drugs Business (2024-2024) & (US$ Million)
Table 112. ValiRx Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Endometriosis Drugs Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Endometriosis Drugs Market Share by Type: 2022 VS 2034
Figure 3. Hormonal Therapy Features
Figure 4. Add-back Medication Features
Figure 5. Progestogens Features
Figure 6. Chinese Herbs Features
Figure 7. Global Endometriosis Drugs Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Endometriosis Drugs Market Share by Application: 2022 VS 2034
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Research Institutes Case Studies
Figure 12. Endometriosis Drugs Report Years Considered
Figure 13. Global Endometriosis Drugs Market Size (US$ Million), Year-over-Year: 2024-2034
Figure 14. Global Endometriosis Drugs Market Size, (US$ Million), 2024 VS 2022 VS 2034
Figure 15. Global Endometriosis Drugs Market Share by Region: 2022 VS 2034
Figure 16. Global Endometriosis Drugs Market Share by Players in 2022
Figure 17. Global Top Endometriosis Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Endometriosis Drugs as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Endometriosis Drugs Revenue in 2022
Figure 19. North America Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 20. North America Endometriosis Drugs Market Share by Country (2024-2034)
Figure 21. United States Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 22. Canada Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 23. Europe Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 24. Europe Endometriosis Drugs Market Share by Country (2024-2034)
Figure 25. Germany Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 26. France Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 27. U.K. Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 28. Italy Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 29. Russia Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 30. Nordic Countries Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 31. Asia-Pacific Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 32. Asia-Pacific Endometriosis Drugs Market Share by Region (2024-2034)
Figure 33. China Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 34. Japan Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 35. South Korea Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 36. Southeast Asia Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 37. India Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 38. Australia Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 39. Latin America Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 40. Latin America Endometriosis Drugs Market Share by Country (2024-2034)
Figure 41. Mexico Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 42. Brazil Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 43. Middle East & Africa Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 44. Middle East & Africa Endometriosis Drugs Market Share by Country (2024-2034)
Figure 45. Turkey Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 46. Saudi Arabia Endometriosis Drugs Market Size YoY Growth (2024-2034) & (US$ Million)
Figure 47. AbbVie Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 48. Astellas Pharma Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 49. AstraZeneca Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 50. Debiopharm Group Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 51. Evotec Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 52. Kissei Pharmaceutical Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 53. Neurocrine Biosciences Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 54. ObsEva Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 55. Pfizer Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 56. Repros Therapeutics Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 57. Roivant Sciences Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 58. Takeda Pharmaceutical Company Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 59. ValiRx Revenue Growth Rate in Endometriosis Drugs Business (2024-2024)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed